CME Group Inc (CME) Stake Increased by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in CME Group Inc (NASDAQ:CME) by 135.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 134,913 shares of the financial services provider’s stock after buying an additional 77,593 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in CME Group were worth $22,204,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Securian Asset Management Inc increased its stake in CME Group by 1.1% in the 1st quarter. Securian Asset Management Inc now owns 36,653 shares of the financial services provider’s stock valued at $6,032,000 after purchasing an additional 414 shares in the last quarter. Arrow Financial Corp increased its stake in CME Group by 98.3% in the 1st quarter. Arrow Financial Corp now owns 575 shares of the financial services provider’s stock valued at $95,000 after purchasing an additional 285 shares in the last quarter. World Asset Management Inc increased its stake in CME Group by 2.3% in the 1st quarter. World Asset Management Inc now owns 21,234 shares of the financial services provider’s stock valued at $3,495,000 after purchasing an additional 484 shares in the last quarter. Bank of Montreal Can increased its stake in CME Group by 59.5% in the 1st quarter. Bank of Montreal Can now owns 769,685 shares of the financial services provider’s stock valued at $126,677,000 after purchasing an additional 287,236 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its position in CME Group by 1.0% during the first quarter. Assenagon Asset Management S.A. now owns 25,517 shares of the financial services provider’s stock worth $4,200,000 after buying an additional 259 shares in the last quarter. 84.83% of the stock is owned by institutional investors and hedge funds.

In related news, Director Jeffrey M. Bernacchi sold 10,087 shares of CME Group stock in a transaction on Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total value of $1,794,880.78. Following the transaction, the director now owns 42,004 shares in the company, valued at $7,474,191.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of CME Group stock in a transaction on Wednesday, April 3rd. The shares were sold at an average price of $168.27, for a total value of $420,675.00. Following the completion of the transaction, the chief financial officer now owns 35,354 shares in the company, valued at approximately $5,949,017.58. The disclosure for this sale can be found here. Insiders have sold 28,489 shares of company stock worth $4,948,996 in the last 90 days. Insiders own 1.20% of the company’s stock.

CME has been the subject of several recent research reports. BidaskClub downgraded CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, January 9th. Jefferies Financial Group reissued a “buy” rating and set a $204.00 price target on shares of CME Group in a research report on Wednesday, January 9th. Bank of America reissued a “neutral” rating and set a $191.00 price target (down previously from $200.00) on shares of CME Group in a research report on Friday, January 11th. They noted that the move was a valuation call. Sanford C. Bernstein reissued an “outperform” rating and set a $210.00 price target on shares of CME Group in a research report on Friday, February 15th. Finally, JPMorgan Chase & Co. initiated coverage on CME Group in a research report on Friday, February 15th. They set an “underweight” rating and a $164.00 price target for the company. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $192.00.

CME stock opened at $179.01 on Monday. CME Group Inc has a 52-week low of $153.90 and a 52-week high of $197.08. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market cap of $64.05 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 3.66 and a beta of 0.29.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.02. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter last year, the firm earned $1.12 earnings per share. The business’s revenue was up 37.4% on a year-over-year basis. As a group, equities research analysts predict that CME Group Inc will post 6.81 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://sportsperspectives.com/2019/04/29/cme-group-inc-cme-stake-increased-by-mitsubishi-ufj-kokusai-asset-management-co-ltd.html.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: How does a reverse stock split work?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.